Smith L M, McWhorter A R, Masters L L, Shellam G R, Redwood A J
Discipline of Microbiology and Immunology, School of Biomedical, Biochemical and Chemical Sciences, University of Western Australia, 35 Stirling Highway, Crawley, WA 6009, Australia.
J Virol. 2008 Jul;82(13):6689-96. doi: 10.1128/JVI.00160-08. Epub 2008 Apr 16.
Murine cytomegalovirus (MCMV) is widely used to model human cytomegalovirus (HCMV) infection. However, it is known that serially passaged laboratory strains of HCMV differ significantly from recently isolated clinical strains of HCMV. It is therefore axiomatic that clinical models of HCMV using serially passaged strains of MCMV may not be able to fully represent the complexities of the system they are attempting to model and may not fully represent the complex biology of MCMV. To determine whether genotypic and phenotypic differences also exist between laboratory strains of MCMV and wild derived strains of MCMV, we sequenced the genomes of three low-passage strains of MCMV, plus the laboratory strain, K181. We coupled this genetic characterization to their phenotypic characteristics. In contrast to what is seen with HCMV (and rhesus CMV), there were no major genomic rearrangements in the MCMV genomes. In addition, the genome size was remarkably conserved between MCMV strains with no major insertions or deletions. There was, however, significant sequence variation between strains of MCMV, particularly at the genomic termini. These more subtle genetic differences led to considerable differences in in vivo replication with some strains of MCMV, such as WP15B, replicating preferentially in otherwise-MCMV-resistant C57BL/6 mice. CBA mice were no more resistant to MCMV than C57BL/6 mice and for some MCMV strains appeared to control infection less well than C57BL/6 mice. It is apparent that the previously described host resistance patterns of inbred mice and MCMV are not consistently applicable for all MCMV strains.
小鼠巨细胞病毒(MCMV)被广泛用于模拟人类巨细胞病毒(HCMV)感染。然而,已知连续传代的HCMV实验室菌株与最近分离的HCMV临床菌株存在显著差异。因此,使用连续传代的MCMV菌株构建HCMV临床模型可能无法充分代表其试图模拟的系统的复杂性,也可能无法完全体现MCMV的复杂生物学特性,这是不言而喻的。为了确定MCMV实验室菌株和野生来源菌株之间是否也存在基因型和表型差异,我们对三株低传代MCMV菌株以及实验室菌株K181的基因组进行了测序。我们将这种基因特征与其表型特征相结合。与HCMV(和恒河猴CMV)不同,MCMV基因组中没有主要的基因组重排。此外,MCMV菌株之间的基因组大小显著保守,没有主要的插入或缺失。然而,MCMV菌株之间存在显著的序列变异,特别是在基因组末端。这些更细微的基因差异导致了MCMV菌株在体内复制方面的显著差异,例如某些MCMV菌株,如WP15B,在原本对MCMV有抗性的C57BL/6小鼠中优先复制。CBA小鼠对MCMV的抗性并不比C57BL/6小鼠更强,而且对于某些MCMV菌株,其控制感染的能力似乎不如C57BL/6小鼠。显然,先前描述的近交系小鼠和MCMV的宿主抗性模式并不始终适用于所有MCMV菌株。